Hydroxymethylglutaryl-CoA Reductase Inhibitors

All categories
DBCAT000391Therapeutic categoryC10AA

Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis. A DrugBank category of 10 drugs. 8 of them are approved.

ATC classification
Part of
Lipid Regulating Agents
Also known as
HMG Co A Reductase Inhibitors · HMG Co A Statins · HMG Co-A Reductase Inhibitors · HMG Co-A Statins · HMG CoA Reductase Inhibitors
Drugs

What you can answer from here — as of June 06, 2018

10DrugsEach linked to its full drug card
Listed above
6Drug targetsEvery drug–target pair in the class, with bond type
Sign in
14,284Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
4Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Hydroxymethylglutaryl-CoA Reductase Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In